Projections in donor organs available for liver transplantation in the United States: 2014-2025

Liver Transplantation

Volumn 21, Issue 6, 2015, Pages 855-863

  Parikh, Neehar D ^a   Hutton, David ^b   Marrero, Wesley ^c   Sanghani, Kunal ^c   Xu, Yongcai ^c   Lavieri, Mariel ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CADAVER DONOR; HEART DEATH; HISPANIC; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MONTE CARLO METHOD; OBESITY; ORGAN DONOR; POPULATION; POPULATION GROWTH; PRIORITY JOURNAL; RACE; SECONDARY ANALYSIS; SENSITIVITY ANALYSIS; SEX; UNITED STATES; DONOR; FORECASTING; SUPPLY AND DISTRIBUTION;

FORECASTING; HUMANS; LIVER TRANSPLANTATION; MONTE CARLO METHOD; TISSUE DONORS; UNITED STATES;

EID: 84930037767     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24136     Document Type: Article

References (36)

1. Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH,. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the surveillance, epidemiology, and end results registry. Liver Transpl 2014; 20: 528-535.
2. Orman ES, Barritt AS, 4th, Wheeler SB, Hayashi PH,. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl 2013; 19: 59-68.
3. Dienstag JL, Cosimi AB,. Liver transplantation-a vision realized. N Engl J Med 2012; 367: 1483-1485.
4. Kadry Z, Schaefer EW, Uemura T, Shah AR, Schreibman I, Riley TR, 3rd. Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States. J Hepatol 2012; 56: 618-625.
5. Northup PG, Intagliata NM, Shah NL, Pelletier SJ, Berg CL, Argo CK,. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. Hepatology 2015; 61: 285-291.
6. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW,. Major challenges limiting liver transplantation in the United States. Am J Transplant 2011; 11: 1773-1784.
7. Broomhead RH, Patel S, Fernando B, O'Beirne J, Mallett S,. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transpl 2012; 18: 771-778.
8. Axelrod DA,. Balancing accountable care with risk aversion: transplantation as a model. Am J Transplant 2013; 13: 7-8.
9. Werner CA,. The Older Population: 2010. Washington, DC: United States Census Bureau; 2011.
10. World Population Aging 2009. New York, NY: United Nations; 2009.
11. Eurostat Statistics Explained. Population structure and ageing 2012. http://ec.europa.eu/eurostat/statistics-explained/index.php/Population
12. Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, et al., Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007; 84: 331-339.
13. Skinner AC, Skelton JA,. Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr 2014; 168: 561-566.
14. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al., Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 2014; 312: 1218-1226.
15. Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, et al., Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl 2013; 19: 437-449.
16. Schneider AL, Lazo M, Selvin E, Clark JM,. Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity (Silver Spring) 2014; 22: 292-299.
17. Centers for Disease Control and Prevention. CDC WONDER. http://wonder.cdc.gov/. Accessed February 12, 2014.
18. US Census Bureau. Population estimates. https://www.census.gov/popest/data/intercensal/index.html. Accessed March 11, 2014.
19. Flegal KM, Carroll MD, Kit BK, Ogden CL,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
20. US Census Bureau. 2012 national population projections: Summary tables. http://www.census.gov/population/projections/data/national/2012/summarytables.html. Accessed March 16, 2014.
21. Weldon Cooper Center for Public Service. University of Virginia. National Population Projections. http://www.coopercenter.org/demographics/national-population-projections. Accessed January 15, 2015.
22. Salim A, Ley EJ, Berry C, Schulman D, Navarro S, Zheng L, Chan LS,. Increasing organ donation in Hispanic Americans: the role of media and other community outreach efforts. JAMA Surg 2014; 149: 71-76.
23. Li D, Hawley Z, Schnier K,. Increasing organ donation via changes in the default choice or allocation rule. J Health Econ 2013; 32: 1117-1129.
24. Doyle MB, Vachharajani N, Wellen JR, Lowell JA, Shenoy S, Ridolfi G, et al., A novel organ donor facility: a decade of experience with liver donors. Am J Transplant 2014; 14: 615-620.
25. Graham JA, Guarrera JV,. "Resuscitation" of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol 2014; 61: 418-431.
26. Hall EC, Boyarsky BJ, Deshpande NA, Garonzik-Wang JM, Berger JC, Dagher NN, Segev DL,. Perioperative complications after live-donor hepatectomy. JAMA Surg 2014; 149: 288-291.
27. Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, et al., Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant 2012; 12: 1208-1217.
28. Bardach NS, Wang JJ, De Leon SF, Shih SC, Boscardin WJ, Goldman LE, Dudley RA,. Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial. JAMA 2013; 310: 1051-1059.
29. Jha AK,. Time to get serious about pay for performance. JAMA 2013; 309: 347-348.
30. Calikoglu S, Murray R, Feeney D,. Hospital pay-for-performance programs in Maryland produced strong results, including reduced hospital-acquired conditions. Health Aff (Millwood) 2012; 31: 2649-2658.
31. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al.,; for ION-1 Investigators. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014; 370: 1889-1898.
32. Brennan T, Shrank W,. New expensive treatments for hepatitis C infection. JAMA 2014; 312: 593-594.
33. Wong RJ, Cheung R, Ahmed A,. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 2014; 59: 2188-2195.
34. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al., Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624-633.
35. Janssen I, Katzmarzyk PT, Ross R,. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 2005; 53: 2112-2118.
36. Starzl TE,. Implied consent for cadaveric organ donation. JAMA 1984; 251: 1592.